Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Rubin Lab
Explore this Website
Home
News
About Us
Research
Lab Team
Publications
Resources
Toggle Resources menu options
FISH
Profiler
Tracking Samples
Weill Cornell Medicine
Care
Discover
Teach
Home
News
About Us
Research
Lab Team
Publications
Resources
Home
Publications
Publications
Found 10 results
Author
Title
Type
Year
Filters:
First Letter Of Title
is
C
[Clear All Filters]
2016
Rubin MA
,
Elemento O
,
Sboner A
,
Imielinski M
,
Pisapia D
,
Fernandes H
,
Zia H
,
Huang L
,
Tavassoli P
,
Kluk M
. 2016.
The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretation
.
JAMIA.
D'Alfonso TM
,
Subramaniyam S
,
Ginter PS
,
Mosquera JMiguel
,
MacDonald TY
,
Noorzad Z
,
Orta LY
,
Liu Y-F
,
Rubin MA
,
Shin SJ
. 2016.
Characterization of the leiomyomatous variant of myofibroblastoma: a rare subset distinct from other smooth muscle tumors of the breast.
.
Hum Pathol.
Fontugne J
,
Davis K
,
Palanisamy N
,
Udager A
,
Mehra R
,
McDaniel AS
,
Siddiqui J
,
Rubin MA
,
Mosquera JMiguel
,
Tomlins SA
. 2016.
Clonal evaluation of prostate cancer foci in biopsies with discontinuous tumor involvement by dual ERG/SPINK1 immunohistochemistry.
.
Mod Pathol. 29(2):157-65.
Faltas BM
,
Prandi D
,
Tagawa ST
,
Molina AM
,
Nanus DM
,
Sternberg C
,
rosenberg jonathan
,
Mosquera JMiguel
,
Robinson B
,
Elemento O
et al.
. 2016.
Clonal evolution of chemotherapy-resistant urothelial carcinoma.
.
Nat Genet. 48(12):1490-1499.
Gayvert KM
,
Dardenne E
,
Cheung C
,
Boland MRegina
,
Lorberbaum T
,
Wanjala J
,
Chen Y
,
Rubin MA
,
Tatonetti NP
,
Rickman DS
et al.
. 2016.
A Computational Drug Repositioning Approach for Targeting Oncogenic Transcription Factors.
.
Cell Rep. 15(11):2348-56.
2015
Feng FY
,
de Bono JS
,
Rubin MA
,
Knudsen KE
. 2015.
Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function.
.
Mol Cell. 58(6):925-34.
2013
Mosquera JMiguel
,
Beltran H
,
Park K
,
MacDonald TY
,
Robinson BD
,
Tagawa ST
,
Perner S
,
Bismar TA
,
Erbersdobler A
,
Dhir, iv R
et al.
. 2013.
Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.
.
Neoplasia. 15(1):1-10.
2011
Rubin MA
,
Maher CA
,
Chinnaiyan AM
. 2011.
Common gene rearrangements in prostate cancer.
.
J Clin Oncol. 29(27):3659-68.
2008
Mosquera J-M
,
Perner S
,
Genega EM
,
Sanda M
,
Hofer MD
,
Mertz KD
,
Paris PL
,
Simko J
,
Bismar TA
,
Ayala G
et al.
. 2008.
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications.
.
Clin Cancer Res. 14(11):3380-5.
2005
Setlur SR
,
Rubin MA
. 2005.
Current thoughts on the role of the androgen receptor and prostate cancer progression.
.
Adv Anat Pathol. 12(5):265-70.